Catalyst Pharmaceuticals Inc (CPRX) ticks all the boxes for top investors with its surprise performance of -10.29% last month.

A new trading day began on Tuesday, with Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) stock price down -3.05% from the previous day of trading, before settling in for the closing price of $15.74. CPRX’s price has ranged from $11.09 to $18.22 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


A company in the Healthcare sector has jumped its sales by 4106.79% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 88.36%. With a float of $99.87 million, this company’s outstanding shares have now reached $107.12 million.

In an organization with 167 employees, it is important to assess its efficiency.

Catalyst Pharmaceuticals Inc (CPRX) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Catalyst Pharmaceuticals Inc is 15.27%, while institutional ownership is 64.92%. The most recent insider transaction that took place on Mar 27 ’24, was worth 411,000. In this transaction Chief Compliance/Legal Officer of this company sold 25,000 shares at a rate of $16.44, taking the stock ownership to the 124,433 shares. Before that another transaction happened on Dec 15 ’23, when Company’s Director sold 14,000 for $14.39, making the entire transaction worth $201,420. This insider now owns 0 shares in total.

Catalyst Pharmaceuticals Inc (CPRX) Latest Financial update

In its latest quarterly report, released on 12/30/2023, the company reported earnings of $0.31 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.3 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 88.36% per share during the next fiscal year.

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Trading Performance Indicators

Here are Catalyst Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.52.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.61, a number that is poised to hit 0.22 in the next quarter and is forecasted to reach 1.60 in one year’s time.

Technical Analysis of Catalyst Pharmaceuticals Inc (CPRX)

Let’s dig in a bit further. During the last 5-days, its volume was 1.11 million. That was inferior than the volume of 1.5 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 13.11%. Additionally, its Average True Range was 0.65.

During the past 100 days, Catalyst Pharmaceuticals Inc’s (CPRX) raw stochastic average was set at 57.22%, which indicates a significant increase from 5.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.07% in the past 14 days, which was lower than the 52.35% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $15.04, while its 200-day Moving Average is $13.99. However, in the short run, Catalyst Pharmaceuticals Inc’s stock first resistance to watch stands at $15.43. Second resistance stands at $15.61. The third major resistance level sits at $15.75. If the price goes on to break the first support level at $15.11, it is likely to go to the next support level at $14.97. The third support level lies at $14.79 if the price breaches the second support level.

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Key Stats

With a market capitalization of 1.80 billion, the company has a total of 117,863K Shares Outstanding. Currently, annual sales are 398,200 K while annual income is 71,410 K. The company’s previous quarter sales were 110,570 K while its latest quarter income was 34,840 K.